In 2016, a Molex customer and leader in the development of sleep and respiratory devices, began developing a ventilator with support from a division of the US Department of Health and Human Services. The purpose was to prepare for the needs of a potential pandemic. When the COVID-19 pandemic hit in early 2020, this device — a portable hospital-to-home ventilator — had just received FDA approval and the company needed to act quickly to ensure production could meet the newly increased demand.
As a leading healthcare supplier, our customer has always been focused on delivering the best solutions to the market through continuous improvement and innovation. By offering the latest technology in a more economical package than prior models, this new device delivers noninvasive (NIV) and invasive (IV) ventilation and was designed to remain with patients as they transition from hospital to home.
The company is working to meet new demands which amount to more than 18 times the normal production volume, and Molex is stepping in to help ensure critical cable assemblies are available.